ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. Results for "C18H30N2O5"
ID CAS Name Synonyms Molecular Formula Category
1383910-22-3PeramivirPeramivir
Peramivir Impurity
Peramivir impurities2
Peramivir impurities448
(1R,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid
(1R,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2- hydroxycyclopentane-1-carboxylic acid hydrate
methyl (3aS,4S,6R,6aR)-6-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-4-carboxylate
4H-Cyclopent[d]isoxazole-4-carboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-, methyl ester, (3aS,4S,6R,6aR)-
C18H30N2O5Impurity reference substance; Paramivir impurity; 189-Paramivir; Reference substance-impurity reference substance
2383910-24-5Peramivir ImpurityPeramivir Impurity
Peramivir impurities6
methyl (3aR,4S,6R,6aS)-6-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-4-carboxylate
4H-Cyclopent[d]isoxazole-4-carboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-, methyl ester, (3aR,4S,6R,6aS)-
C18H30N2O5Impurity control;Peramivir impurity;Control-impurity control
31191921-01-3Oseltamivir-acetateOseltamivir-acetate
Oseltamivir Impurity455
Oseltamivir Impurity456
(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate
C18H30N2O5Oseltamivir;100-Oseltamivir
4220156-99-0N-Cbz-4,7,10-trioxa-1,13-tridecanediamineCBZ-N-amido-dPEG3-amine
CBZ-N-amido-dPEG??-amine
N-Cbz-4,7,10-trioxa-1,13-tridecanediamine
benzylN-[3-[2-[2-(3-aminopropoxy)ethoxy]ethoxy]propyl]carbamate
BENZYL N-[3-[2-[2-(3-AMINOPROPOXY)ETHOXY]ETHOXY]PROPYL]CARBAMATE
6,9,12-Trioxa-2-azapentadecanoic acid, 15-amino-, phenylmethyl ester
(3-{2-[2-(3-Aminopropoxy)ethoxy]ethoxy}-propyl)-carbamic acid benzyl ester
C18H30N2O5PEG Products-Cbz-PEG
52101206-19-12,8-di-Boc-2,8-DIAZA-SPIRO[5.4]DECAN-1-ONE2,8-di-Boc-2,8-DIAZA-SPIRO[5.4]DECAN-1-ONE
2,7-Diazaspiro[4.5]decane-2,7-dicarboxylic acid, 6-oxo-, 2,7-bis(1,1-dimethylethyl) ester
C18H30N2O5
63'-[Bis(3-ethoxy-2-hydroxypropyl)amino]acetanilide3'-[Bis(3-ethoxy-2-hydroxypropyl)amino]acetanilideC18H30N2O5
7823780-55-8Dodecanamide, N-[2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl]-Dodecanamide, N-[2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl]-C18H30N2O5
83-(2-(2-(3-Benzyloxycarbonylaminopropoxy)ethoxy)ethoxy)propylamine3-(2-(2-(3-Benzyloxycarbonylaminopropoxy)ethoxy)ethoxy)propylamine
Z-NH-dPEG3)-NH2
C18H30N2O5
92-Oxo-1,2,3,6-tetrahydropyrimidine-4,6-dicarboxylic acid 4-hexyl 6-hexyl ester2-Oxo-1,2,3,6-tetrahydropyrimidine-4,6-dicarboxylic acid 4-hexyl 6-hexyl esterC18H30N2O5
102820170-76-92-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)nitrosoamino]-2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)nitrosoamino]-
Bisoprolol Impurity 55 (N-Nitroso Bisoprolol)
C18H30N2O5
11229613-93-8(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid Methyl esterPeramivir Intermediate 2
Methyl (1S,4R)-4-[(tert-butoxycarbonyl)amino]cyclopent-2-ene-1-carboxylate
methyl 2-((1R,4R)-4-((tert-butoxycarbonyl)amino)cyclopent-2-en-1-yl)acetate
(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid Methyl ester
(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester
2-cyclopentene-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (1S,4R)-
(3aR,4R,6S,6aS)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cy
Methyl 4-{[(tert-butoxy)carbonyl]aMino}-3-(pentan-3-yl)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,2]oxazole-6-carboxylate
(3aR,4R,6S,6aS)-methyl4-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate
(3Ar,4R,6S,6As)-Methyl 4-(Tert-Butoxycarbonyl)-3-(Pentan-3-Yl)-4,5,6,6A-Tetrahydro-3Ah-Cyclopenta[D]Isoxazole-6-Carboxylate
(3aR,4R,6S,6aS)-Methyl 4-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate
(3aR,4R,6S)-Methyl-4-((tert-butoxycarbonyl)aMino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate
(3aR,4R,6S,6aS)-4-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic Acid Methyl Ester
(3aR,4R,6S,6aS)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic acid methyl ester
C18H30N2O5Intermediates;Pharmaceutical intermediates
12296782-05-33-Indolizinecarboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]octahydro-5-oxo-, 1,1-dimethylethyl ester, (3S,6S,8aS)-3-Indolizinecarboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]octahydro-5-oxo-, 1,1-dimethylethyl ester, (3S,6S,8aS)-C18H30N2O5
13(3aR,4R,6S,6aS)-Methyl 4-(tert-butoxycarbonylaMino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate(3aR,4R,6S,6aS)-Methyl 4-(tert-butoxycarbonylaMino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylateC18H30N2O5
14383910-25-6methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylatePeramivir impurities4
Peramivir impurities450
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate
4H-Cyclopent[d]isoxazole-6-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-, methyl ester, (3aS,4R,6S,6aR)-
C18H30N2O5Impurity reference substance; peramivir impurity; reference substance-impurity reference substance

Suppliers

ID CAS Product Name Suppliers Descriptions
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002